Symbol: |
SV2B
|
Description: |
synaptic vesicle glycoprotein 2B [Source:HGNC Symbol;Acc:16874]
|
Location: |
Chr15:91643180-91844539[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:408
Gene |
Compound |
Gen_sig |
Exp_pattern |
SV2B |
Camptothecin ethylglycinate ester hydrochloride |
0.017 |
Down |
SV2B |
NSC 607281 |
0.02 |
Down |
SV2B |
Camptothecin hemisuccinate sodium salt |
0.035 |
Down |
SV2B |
Camptothecin lysinate HCl |
0.024 |
Down |
SV2B |
NSC 611229 |
0.035 |
Down |
SV2B |
NSC 614053 |
0.024 |
Down |
SV2B |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.005 |
Down |
SV2B |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.049 |
Down |
SV2B |
3-Deazaneplanocin, hydrochloride |
0.043 |
Down |
SV2B |
Aspidospermin |
0.013 |
Down |
SV2B |
2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- |
0.031 |
Down |
SV2B |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.033 |
Up |
SV2B |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.03 |
Up |
SV2B |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.047 |
Down |
SV2B |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.001 |
Down |
Expression pattern: Sensitivity / Resistance
Total:28 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:189
Total:13 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
SV2B |
ENST00000330276 |
hsa-mir-337-3p |
Chr14:101340890-101340911[+] |
SV2B |
ENST00000330276 |
hsa-mir-92b-5p |
Chr1:155164987-155165008[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|